Biopharma Perspective – Global Biopharma News, Explained with Perspective

Biopharma Perspective

Curious about what’s next in pharma and biotech?

Explore the scientific breakthroughs, clinical milestones, and industry trends shaping the future of global healthcare.

Latest Articles

Epicrispr Raises $90 Million to Silence Disease Genes Without Cutting DNA

August 12, 2026
Jazz Bets $1.32 Billion on a Precision Therapy for Rare Epilepsy

August 11, 2026
Moderna Wins FDA Approval for the First mRNA Flu Vaccine

August 10, 2026
Tarsus Bets Up to $800 Million on a Deuterated Vitamin A Drug

August 7, 2026
Can Sionna Challenge Vertex’s Cystic Fibrosis Empire?

August 7, 2026
Jazz to Withdraw Zepzelca’s Second-Line SCLC Indication After Phase 3 Failure

August 5, 2026
Curium to Acquire Lantheus in an $8 Billion Radiopharma Deal

August 4, 2026
AstraZeneca and Bristol Myers Squibb Explore a $400 Billion Pharma Megadeal

August 3, 2026
Sanofi’s Pipeline Reset Signals a New Era of R&D Discipline

July 31, 2026
J&J Takes a Profit Hit to Secure an In Vivo CAR-T Platform

July 30, 2026